Stock DNA
Pharmaceuticals & Biotechnology
JPY 36,919 Million (Small Cap)
239.00
NA
0.00%
-0.90
2.29%
5.17
Revenue and Profits:
Net Sales:
466 Million
(Quarterly Results - Mar 2026)
Net Profit:
-58 Million
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
51.00%
EBIT Growth (5y)
21.23%
EBIT to Interest (avg)
-566.35
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.19
Tax Ratio
34.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
139.88%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
239
Industry P/E
Price to Book Value
5.46
EV to EBIT
139.70
EV to EBITDA
116.93
EV to Capital Employed
44.32
EV to Sales
12.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
31.72%
ROE (Latest)
2.29%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Change(%)
Net Sales
2,594.10
0.00
NA
Operating Profit (PBDIT) excl Other Income
278.70
0.00
NA
Interest
0.10
0.00
NA
Exceptional Items
0.00
0.00
NA
Consolidate Net Profit
163.40
0.00
NA
Operating Profit Margin (Excl OI)
89.90%
0.00%
NA
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period






